BO-264

N/A

Report date: 2023/04/07 16:11:15
NME

Base Information

Drug NameBO-264
Drug Alias NameBO-264
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransforming acidic coiled-coil-containing protein 3 inhibitors
TargetsTransforming acidic coiled-coil-containing protein 3
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBilkent University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A